Log in to save to my catalogue

Rational development of multicomponent mRNA vaccine candidates against mpox

Rational development of multicomponent mRNA vaccine candidates against mpox

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2789712973

Rational development of multicomponent mRNA vaccine candidates against mpox

About this item

Full title

Rational development of multicomponent mRNA vaccine candidates against mpox

Publisher

United States: Taylor & Francis

Journal title

Emerging microbes & infections, 2023-12, Vol.12 (1), p.2192815-2192815

Language

English

Formats

Publication information

Publisher

United States: Taylor & Francis

More information

Scope and Contents

Contents

The re-emerging mpox (formerly monkeypox) virus (MPXV), a member of Orthopoxvirus genus together with variola virus (VARV) and vaccinia virus (VACV), has led to public health emergency of international concern since July 2022. Inspired by the unprecedent success of coronavirus disease 2019 (COVID-19) mRNA vaccines, the development of a safe and eff...

Alternative Titles

Full title

Rational development of multicomponent mRNA vaccine candidates against mpox

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2789712973

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2789712973

Other Identifiers

ISSN

2222-1751

E-ISSN

2222-1751

DOI

10.1080/22221751.2023.2192815

How to access this item